Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets

Contributed by: GlobeNewswire

Tags

Medical Cannabis

More Like This

Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand

Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal

GlobeNewswire associated0

Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings

Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal

Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026

Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis

Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains

GlobeNewswire associated0

Tilray Medical Receives Italy’s First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use